Neuroone Medical Technologies (NMTC) Short-term Investments (2022 - 2023)

Neuroone Medical Technologies (NMTC) posted Short-term Investments of $995432.0 for Q1 2023, down 66.54% on a QoQ basis from $3.0 million in Q4 2022.

Neuroone Medical Technologies (NMTC) Short-term Investments (2022 - 2023) Analysis & Trends

Neuroone Medical Technologies' Short-term Investments history runs 2 years deep, the most recent figure standing at $995432.0 for Q1 2023.

  • Quarterly Short-term Investments changed N/A year-over-year to $995432.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $995432.0 (changed N/A YoY) and the FY2022 annual result came in at $3.0 million, changed N/A from the prior year.
  • Short-term Investments was $995432.0 for Q1 2023 at Neuroone Medical Technologies, down from $3.0 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $3.0 million in Q3 2022 and bottomed at $995432.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Neuroone Medical Technologies 7.99 Mn 5.19 Mn 990,264.00

Historic Data

Download Data
DateValue
Mar 31, 2023 995,432.00
Dec 31, 2022 2.98 Mn
Sep 30, 2022 2.98 Mn